Spotlight on Peginterferon-α-2a (40 kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection†

Author： Keam Susan J.   Cvetković Risto S.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.23, Iss.1, 2009-01, pp. : 63-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peginterferon- -2a (40kD) and Ribavirin in Patients with Chronic Hepatitis C: A Phase II Open-Label Study

By Sulkowski M.  

BioDrugs, Vol. 16, Iss. 2, 2002-02 ,pp. : 105-109

Adis International

Access to resources Recommend Favorite

Spotlight on Peginterferon- -2a (40KD) in Chronic Hepatitis C

By Perry C.M.   Jarvis B.  

BioDrugs, Vol. 16, Iss. 3, 2002-01 ,pp. : 213-217

Adis International

Access to resources Recommend Favorite

Interleukin-2 Plus Ribavirin Versus Interferon- -2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon- -2b Treatment

By Mariano Malaguarnera  

BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 407-413

Adis International

Access to resources Recommend Favorite

Interferon- Alone versus Interferon- plus Ribavirin in Patients with Chronic Hepatitis C Not Responding to Previous Interferon- Treatment

By Tripi S.  

BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 299-304

Adis International

Access to resources Recommend Favorite

Interferon- (IFN ) Daily Dose Versus IFN Plus Ribavirin for Treatment-Naive Chronic Hepatitis C Patients Infected by Genotype 1b

By Scotto G.  

BioDrugs, Vol. 17, Iss. 4, 2003-01 ,pp. : 281-286

Adis International

Access to resources Recommend Favorite